TY - JOUR
T1 - The prognostic impact of preoperative and postoperative chemoradiation in clinical Stage II and III esophageal squamous cell carcinomas
AU - Chen, Hui Shan
AU - Wu, Shiao Chi
AU - Hsu, Po Kuei
AU - Huang, Chien Sheng
AU - Liu, Chia Chuan
AU - Wu, Yu Chung
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc.
PY - 2015/6/9
Y1 - 2015/6/9
N2 - While preoperative chemoradiation followed by surgery (pre-OP CRT) has been widely applied in the treatment of patients with esophageal cancer, some studies have shown a survival benefit of postoperative chemoradiation (post-OP CRT). The optimal combination of multimodality therapy and the sequence of surgery and chemoradiation for esophageal cancer remain to be investigated. A total of 1385 patients with clinical stage II and III esophageal squamous cell carcinoma (ESCC) were included. On the basis of the sequence of surgery and chemoradiation, the patients were grouped as follows: preoperative chemoradiation followed by surgery (pre-OP CRT+S), surgery alone (S), and surgery followed by postoperative chemoradiation (S+post-OP CRT). Propensity score matching analysis was used to identify 78 well-balanced patients in each group for outcome comparison. In all, 753, 339, and 293 patients were in the pre-OP CRT+S, S, and S+post-OP CRT groups, respectively. Before matching, no differences were observed in the overall survival among the patients in these 3 groups (P=0.422). After matching, both the pre-OP CRT+S and S+post-OP CRT groups were significantly associated with a better survival compared with the S group (pre-OP CRT+S vs. S: P<0.001; S+post-OP CRT vs. S: P=0.005). In contrast, the survival was similar between the pre-OP CRT+S and S+post-OP CRT groups (P=0.544). In the subgroup analysis, patients with clinical T3/4 stage tumors or those with a tumor size greater than 5cm were more likely to demonstrate an overall survival benefit from pre-OP CRT compared with post-OP CRT. Both pre-OP CRT and post-OP CRT demonstrated a survival benefit compared with surgery alone, which indicates the importance of trimodality therapy in patients with clinical stage II/III ESCC. However, no survival difference was observed among patients in the pre-OP CRT+S and S+post-OP CRT groups, which suggests that the sequence of surgery and chemoradiation may be irrelevant to the outcome.
AB - While preoperative chemoradiation followed by surgery (pre-OP CRT) has been widely applied in the treatment of patients with esophageal cancer, some studies have shown a survival benefit of postoperative chemoradiation (post-OP CRT). The optimal combination of multimodality therapy and the sequence of surgery and chemoradiation for esophageal cancer remain to be investigated. A total of 1385 patients with clinical stage II and III esophageal squamous cell carcinoma (ESCC) were included. On the basis of the sequence of surgery and chemoradiation, the patients were grouped as follows: preoperative chemoradiation followed by surgery (pre-OP CRT+S), surgery alone (S), and surgery followed by postoperative chemoradiation (S+post-OP CRT). Propensity score matching analysis was used to identify 78 well-balanced patients in each group for outcome comparison. In all, 753, 339, and 293 patients were in the pre-OP CRT+S, S, and S+post-OP CRT groups, respectively. Before matching, no differences were observed in the overall survival among the patients in these 3 groups (P=0.422). After matching, both the pre-OP CRT+S and S+post-OP CRT groups were significantly associated with a better survival compared with the S group (pre-OP CRT+S vs. S: P<0.001; S+post-OP CRT vs. S: P=0.005). In contrast, the survival was similar between the pre-OP CRT+S and S+post-OP CRT groups (P=0.544). In the subgroup analysis, patients with clinical T3/4 stage tumors or those with a tumor size greater than 5cm were more likely to demonstrate an overall survival benefit from pre-OP CRT compared with post-OP CRT. Both pre-OP CRT and post-OP CRT demonstrated a survival benefit compared with surgery alone, which indicates the importance of trimodality therapy in patients with clinical stage II/III ESCC. However, no survival difference was observed among patients in the pre-OP CRT+S and S+post-OP CRT groups, which suggests that the sequence of surgery and chemoradiation may be irrelevant to the outcome.
UR - http://www.scopus.com/inward/record.url?scp=84941212817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941212817&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000001002
DO - 10.1097/MD.0000000000001002
M3 - Article
C2 - 26107665
AN - SCOPUS:84941212817
SN - 0025-7974
VL - 94
SP - e1002
JO - Medicine (United States)
JF - Medicine (United States)
IS - 25
ER -